Clinical Trials Browser

Phase NA × Digestive System Diseases × 90 days × Clear all

Carcinoma, Colonic Diseases, Digestive System Diseases, Digestive System Neoplasms, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Neoplasm Metastasis, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Colorectal Neoplasms, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

NCT06929845 2026-05-19

Organoid Models of Hepatocellular Carcinoma

Phase NA Recruiting

150 enrolled

Gastrointestinal

Digestive System Diseases, Carcinoma, Hepatocellular

NCT01082419 2026-05-14

NARFI

Phase NA Completed

109 enrolled

Gastrointestinal

Digestive System Diseases, Fibrosis, Heart Failure, Carcinoma, Hepatocellular, Liver Cirrhosis

NCT05786482 2026-05-08

EMPOwer

Phase NA Completed

825 enrolled

Gastrointestinal

Anxiety Disorders, Depression, Digestive System Diseases, Heart Failure, Liver Cirrhosis, Liver Cirrhosis, Biliary, Neoplasms, Renal Insufficiency, Chronic

NCT05612347 2026-05-07

COOP

Phase NA Recruiting

8,946 enrolled

Gastrointestinal

Digestive System Diseases, Colorectal Neoplasms

NCT04084249 2026-04-29

ctDNA-guided Surveillance for Stage III CRC, a Randomized Intervention Trial

Phase NA Active not recruiting

359 enrolled

Gastrointestinal

Colonic Diseases, Colonic Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Neoplasms, Rectal Diseases, Rectal Neoplasms, Colorectal Neoplasms

NCT07351071 2026-03-17

SECURE

Phase NA Recruiting

137 enrolled

Gastrointestinal

Colonic Diseases, Digestive System Diseases, Gastrointestinal Diseases, Intestinal Diseases, Postoperative Complications, Rectal Diseases, Rectal Neoplasms, Anastomotic Leak

Clinical Trials

INDIGO

Organoid Models of Hepatocellular Carcinoma

NARFI

EMPOwer

COOP

ctDNA-guided Surveillance for Stage III CRC, a Randomized Intervention Trial

SECURE